retatrutide clinical data 💊🔥 Retatrutide: The Most Powerful Weight-Loss Drug Yet? 🧬📊 New Phase 3 results are turning heads retatrutide, a next-generation triple-agonist targeting GLP-1, GIP and glucagon receptors, is showing unmatched levels of retatrutide heart issues rate: what

Ozempi-mania: Despite the challenges, there may be reason for optimism about the niches future as competition in the weight-loss drug marketplace ramps up

Kathryn Wellen (University of Pennsylvania) for critical reading of our manuscript, Fran Vasquez for help with the CRISPR schematic, Uma Chandran and Jiefei Wang (UPMC Hillman Cancer Center Bioinformatics Core) for help with bioinformatic analysis of the CRISPR screen, and Maureen Lyons (UPMC Hillman Cancer Center Cancer Genomics Core) for help with sequencing of the CRISPR library

Withdrawal from chronic administration of cocaine decreases delta opioid receptor signaling and increases anxiety- and depression-like behaviors in the rat

Why Protein Matters More for Weight Loss on GLP-1 Research shows up to 40% of weight lost on GLP-1 medications can come from muscle, not fat which slows metabolism and raises rebound risk when medication stops

Suanzaoren decoction improves depressive-like behaviors by regulating the microbiota-gut-brain axis via inhibiting TLR4/NFB/NLRP3 inflammation signal pathway